Blood-based circulating tumor DNA mutations as a diagnostic and prognostic biomarker for lung cancer.
Cancer. 2020 Apr 15;126(8):1804-1809. doi: 10.1002/cncr.32699. Epub 2020 Jan 30.
Cancer. 2020.
PMID: 31999831
Free article.